JAPAN Registry of Self-harm and Suicide Attempts: Study protocol and profile in 2022–2023
Abstract
Background
Self-harm and suicide attempts (SA) are a significant cause of emergency department visits in Japan, where over 20,000 suicides occur annually. Each suicide death is estimated to correspond to over 20 attempts, highlighting the urgent need for intervention strategies. Therefore, in 2022, the JAPAN Registry of Self-harm and Suicide Attempts (JA-RSA) was established as the first nationwide prospective registry.
Aim
This study describes the design, objectives, and initial findings of JA-RSA and evaluates its potential to inform national suicide prevention policies.
Methods
JA-RSA collects comprehensive data on patients presented to critical care centers in Japan for self-harm or SA. Between December 2022 and December 2023, data from 1987 registered cases from 44 institutions were analyzed. Patient demographics, self-harm methods, and treatment outcomes were examined and compared with national suicide statistics for 2023.
Results
The mean age of patients was 39.3 years (36.9% male). Self-harm was inflicted through intentional drug overdose (58.2%), jumping from a height (12.1%), self-cutting (11.2%), and hanging (10.8%). Of the 1987 cases, 68.4% required intensive care treatment, 11.9% received outpatient care, and 8.3% died. Compared with national suicide statistics, JA-RSA revealed that more females and individuals aged below 20 engage in self-harm.
Conclusions
JA-RSA provides critical insights into the characteristics and treatment outcomes of patients who engage in self-harm. The registry's findings underscore the need for greater participation of institutions and further improvement in prevention strategies. By offering unique data, JA-RSA could help improve suicide prevention and intervention strategies.
INTRODUCTION
In Japan, over 20,000 people die by suicide each year, making suicide a critical public health concern.1 It is estimated that for every suicide, there are more than 20 attempts, underscoring the scale of the issues.2 A history of one or more previous suicide attempts (SA) or self-harm is recognized as the strongest predictor of death by suicide.3 Consequently, preventing reattempts among suicide attempt survivors is a high-priority objective within comprehensive suicide prevention measures.2, 4
Surveillance plays an essential role in public health practice by guiding prevention efforts, monitoring interventions, and evaluating their outcomes. The importance of establishing surveillance systems for SA has been emphasized by the World Health Organization (WHO).5 Internationally, various models exist. For instance, the National Self-harm Registry Ireland, the world's first national registry for self-harm, has been collecting data from emergency departments for over 20 years, significantly contributing to policy-making and prevention strategies.6
In Japan, suicide attempters account for approximately 15% of patients transported to emergency and critical care centers (ECCCs), where critically ill patients receive initial treatment.7 This indicates that SA consumes significant emergency medical resources, necessitating attention from ECCCs and the establishment of a surveillance system to optimize the allocation of these limited resources.
Although several regions or institutional surveys on SA have been conducted in Japan,8 a continuous nationwide surveillance system has not been established until recently. A comprehensive, real-time, nationwide system could offer valuable insights into the risk and protective factors associated with suicidal behavior, which might otherwise remain unidentified. Comparing SA data with suicide statistics help to identify demographic differences between individuals who attempt suicide and those who die by suicide. These insights can inform targeted interventions, such as providing intensive support for youth and women who are at higher risk of repeated attempts.
In response to these needs, the Japanese Society for Emergency Medicine (JSEM) and the Japan Suicide Countermeasures Promotion Center (JSCP) collaborated to establish the JAPAN Registry of Self-Harm and Suicide Attempts (JA-RSA) in December 2022.9 This registry represents the first nationwide surveillance system for self-harm and SA in Japan. JSEM, an academic society of emergency physicians and other emergency medical professionals, aims to advance and disseminate emergency medical care while enhancing health and welfare nationwide.10 Meanwhile, JSCP, a nationally designated research organization under the Law on Promotion of Surveys and Research to Facilitate Comprehensive and Effective Implementation of Suicide Countermeasures and Utilization, etc. of Outcomes Thereof (Law No. 32 of 2019), is dedicated to creating a society where no one is driven to suicide.11
The JA-RSA initiative has begun continuous data collection and is actively expanding the number of participating institutions. While achieving nationwide participation remains a long-term goal, the preliminary profile of registered cases during the first 13 months provides valuable insights and demonstrates the registry's potential for future analyses. This study primarily aims to describe the initial findings from JA-RSA, the first nationwide registry of self-harm and SA in Japan. As a secondary objective, we also compare these findings with national suicide statistics to provide contextual insights that may inform future prevention strategies.
MATERIALS AND METHODS
Data collection and participants
This study utilized data from the JA-RSA registry, which collects observational data on all cases of self-harm and SA presented to participating ECCCs nationwide. Data were entered into an electronic collection system by trained data registers, adhering to standard procedures. For this study, SA is defined as “injuries or poisoning intentionally self-inflicted,” irrespective of intent or fatality resulting from the behavior. Cases were enrolled based on individual episodes or hospital presentations, meaning that the same patients could potentially appear as multiple entries within a given timeframe. No personally identifiable patient information was collected. Consent was obtained on an opt-out basis, allowing the patient or their families the option to decline participation in the registry.
The analyses included all cases recorded between December 1, 2022 and December 31, 2023. During this period, 44 institutions (14.7% of eligible ECCCs) participated in the registry.12
Data items
- Demographic data: Age, sex, nationality, and social factors such as living arrangements, employment status, and public assistance or disabilities certification.
- Episode-specific details: Date and time of the SA incident, hospital presentation, transportation mode, methods and location of the SA, and alcohol involvement (confirmed via blood and urine tests).
- Clinical data: Vital signs upon hospital presentation, whether the patient experienced suicidal ideation (recorded alongside the job title of the inquiring staff member), pregnancy or postpartum status (for female patients), and outcomes at various points (end of outpatient care, 1 month for inpatients, and discharge data for the discharged patient).
- Psychiatric and support data: Records of psychiatric consultations (e.g., liaison teams, psychiatrists, or psychosomatic physicians), history of SA (self-reported or obtained through other sources), and coordinated with external support organizations.
The method(s) and location of SA were documented in accordance with Japan's national suicide statistics from the National Police Agency.13 Multiple methods could be recorded if applicable.
Hospital information
In collaboration with the Ministry of Health, Labor and Welfare, the JSEM, and JSCP, all 300 ECCCs operating as of the end of 2021 were invited to participate in the registry. Participating institutions provided detailed information on their emergency acceptance system, inpatient bed availability, general and emergency-specific psychiatric care availability, annual patient visits, ambulance acceptances, and projected SA cases per year.
Data analysis
To provide an overview of cases enrolled in the JA-RSA, the basic characteristics of participating institutions and patients were described. Key variables, such as sex, age (categorized as <20 years vs. ≥20 years), and leading SA methods, were compared with 2023 publicly available suicide death statistics1 using the chi-square test. Statistical significance was set at p < 0.05. All analyses were performed using Python version 3.10.12 and the SciPy library version 1.13.1.
RESULTS
A total of 1987 hospital presentations were enrolled in JA-RSA during the study period. Table 1 shows the hospital information for the participating institutions in JA-RSA from 2022 to 2023. The median number of patients per year was 11,832, with a median of 83 SA patients expected annually. Approximately 20% of the hospitals provided tertiary emergency care exclusively, while psychiatric care for emergency patients was available at all hospitals.
n = 44 (total) | |
---|---|
Area, n (%) | |
Hokkaido/Tohoku | 7 (15.9) |
Kanto | 13 (29.5) |
Tokai/Hokuriku | 8 (18.2) |
Kinki | 8 (18.2) |
Chugoku/Shikoku | 3 (6.8) |
Kyushu/Okinawa | 5 (11.4) |
Emergency acceptance system, n (%) | |
Tertiary emergency only | 9 (20.5) |
Tertiary and secondary | 6 (13.6) |
Tertiary, secondary, and primary | 29 (65.9) |
Inpatient beds available, n (%) | 41 (93.2) |
Psychiatric care available, n (%) | 44 (100.0) |
Psychiatric care for emergency patients available, n (%) | 44 (100.0) |
Number of patients visiting per year, mean (SD) | 11,832 (12,029) |
Number of ambulances accepted per year, mean (SD) | 3759 (2797) |
Expected number of patients with self-harm/suicide attempt per year, mean (SD) | 83 (151) |
The basic characteristics of the cases enrolled are presented in Table 2. Over 60% of the patients were female (63.1%), with the highest prevalence observed among those aged 20–29 years (28.7%). The median age was 39.3 years. The most frequently reported method of SA was intentional drug overdose (IOD), accounting for 58.2% of cases, with 7.5% involving multiple methods. Other common methods included jumping from height (12.1%), self-cutting (11.2%), and hanging (10.8%). Notably, 66.4% of patients presented to the hospital outside regular working hours.
n = 1987 | % | |
---|---|---|
Sex | ||
Male | 733 | 36.9 |
Female | 1254 | 63.1 |
Age | ||
<20 years | 253 | 12.7 |
20–29 years | 570 | 28.7 |
30–39 years | 334 | 16.8 |
40–49 years | 244 | 12.3 |
50–59 years | 269 | 13.5 |
60–69 years | 121 | 6.1 |
70–79 years | 100 | 5.0 |
80 years and over | 95 | 4.8 |
Missing | 1 | 0.0 |
Methoda | ||
Intentional drug overdose (IOD) | 1156 | 58.2 |
IOD only | 1069 | 53.8 |
Combined with other method(s) | 87 | 4.4 |
Jumping from height (only or combined) | 240 | 12.1 |
Self-cutting (only or combined) | 223 | 11.2 |
Hanging (only or combined) | 214 | 10.8 |
Other than the above | 213 | 10.7 |
Missing or unidentified | 5 | 0.3 |
Alcohol involvement | ||
Yes | 286 | 14.4 |
No | 1148 | 57.8 |
Missing or unidentified | 553 | 27.8 |
Having suicidal ideation during the episode | ||
Yes | 694 | 34.9 |
No | 356 | 17.9 |
Missing or unidentified | 937 | 47.2 |
Time presented to the hospital | ||
During regular working hours (9 am–5 pm) | 658 | 33.1 |
Outside regular working hours | 1319 | 66.4 |
Missing | 10 | 0.5 |
- a Multiple methods can be selected, so the total count exceeds the total number.
The types of care received and outcomes of the cases are shown in Table 3. Among all the cases, 8.3% were confirmed dead in the outpatient setting. A majority (68.4%) were admitted to the intensive care unit (ICU), while 11.9% returned home after receiving outpatient treatment alone. Among hospitalized patients, 70.5% were discharged within 1 month, and 4.4% died during their stay. Additionally, over 70% of patients received psychiatric consultation during hospitalization, and approximately 60% were referred to or informed about support organizations.
n = 1987 | % | |
---|---|---|
Outcome at the end of the outpatient care | ||
Admission to the ICU | 1360 | 68.4 |
Admission to the general ward | 100 | 5.0 |
Admission to the psychiatry ward | 53 | 2.7 |
Returning home | 237 | 11.9 |
Dead | 165 | 8.3 |
Other | 63 | 3.2 |
Missing | 9 | 0.5 |
Outcome at 1 month (admitted patient only; n = 1513) | ||
Discharged | 1067 | 70.5 |
Transferred to different hospitals | 251 | 16.6 |
Still hospitalized | 119 | 7.9 |
Dead | 67 | 4.4 |
Missing | 9 | 0.6 |
Having psychiatric consultation during the stay in the hospital | ||
Yes | 1429 | 71.9 |
No | 525 | 26.4 |
Missing | 33 | 1.7 |
Having information and/or coordination with support organizations provided | ||
Yes | 1203 | 60.5 |
No | 675 | 34.0 |
Missing | 109 | 5.5 |
Table 4 presents the self-harm and/or SA history and social status of the cases. Nearly half of the cases had a prior history of SA. Among these, 28% were currently employed, and 10% were recipients of public financial assistance. It is worth noting that missing data rates for socioeconomic status items were relatively high, potentially limiting interpretations.
n = 1987 | % | |
---|---|---|
Having a history of self-harm and/or suicide attempt | ||
Yes | 826 | 41.6 |
No | 614 | 30.9 |
Missing or unidentified | 547 | 27.5 |
Having someone living with | ||
Yes | 1373 | 69.1 |
No | 442 | 22.2 |
Missing or unidentified | 172 | 8.7 |
Working status | ||
Employed | 568 | 28.6 |
Unemployed (other than student) | 743 | 37.4 |
Student | 239 | 12.0 |
Missing or unidentified | 437 | 22.0 |
Receiving public assistance | ||
Yes | 207 | 10.4 |
No | 1550 | 78.0 |
Missing or unidentified | 230 | 11.6 |
Having a disability certificate | ||
Yes | 209 | 10.5 |
No | 1283 | 64.6 |
Missing | 495 | 24.9 |
Comparison of profiles with suicide deaths
A comparison of JA-RSA and actual suicide statistics is shown in Table 5. The proportion of males in JA-RSA was significantly lower than that in suicide statistics (36.9% vs. 68.1%, p < 0.001). Conversely, individuals under 20 years of age constituted a significantly higher proportion in JA-RSA compared to suicide statistics (12.7% vs. 3.7%, p < 0.001). Regarding methods, suicide statistics indicated that over 60% of deaths were due to hanging, compared to only 10% in JA-RSA.
JA-RSA, n = 1987 | Suicide statistics, n = 21,837 | p | |||
---|---|---|---|---|---|
n | % | n | % | ||
Male | 733 | 36.9 | 14,862 | 68.1 | <0.001 |
Age < 20 years | 253 | 12.7 | 810 | 3.7 | <0.001 |
Methoda_intentional drug overdose | 1156 | 58.2 | NA | NAb | – |
Methoda_jumping from height | 240 | 12.1 | 2710 | 12.4 | 0.694 |
Methoda_self-cutting | 223 | 11.2 | NA | NAb | – |
Methoda_hanging | 214 | 10.8 | 14,104 | 64.6 | <0.001 |
- a Multiple methods can be selected for one case in JA-RSA.
- b The prevalences of intentional drug overdose and self-cutting in suicide statistics are publicly unavailable, but each is less than that of briquettes, etc. (8.6%).
DISCUSSION
This study introduced the first nationwide prospective registry in Japan for patients with SA presenting to ECCCs. Our findings indicated that over half of the SA cases involved IOD, and nearly 70% of these patients required admission to the ICU. The proportions distribution among self-harm and suicide attempts enrolled in JA-RSA, particularly regarding sex and age, differed substantially from those observed among suicide deaths in national suicide statistics.
JA-RSA focuses on data collection from ECCCs where patients in critical condition are transported, which is unlikely to include patients with relatively mild symptoms. This specificity limits direct comparisons with data from other countries, where national registries often cover all types of emergency departments. Nevertheless, our findings, including the high prevalence of young individuals, women, and cases of overmedication in SA presentations, align with prior reports from Japan and abroad.6, 14-17 Furthermore, the significant disparities between the demographic and clinical profiles of SA patients and those of suicide death cases highlight the need for tailored prevention strategies targeting these at-risk populations and scenarios. JA-RSA data are accessible to researchers at participating institutions, fostering studies aimed at improving suicide prevention and support for suicide attempters.
Several limitations of this study must be acknowledged. First, the JA-RSA data cannot differentiate between repeat visits by the same patients due to technical constraints in personal information management. Addressing this issue is a key objective for the next stage of the registry, as not a few suicide attempters reattempt it.18 Second, the registry currently has an insufficient participation rate among ECCCs, potentially leading to the underrepresentation of cases in some regions. As the coverage of participating institutions increases in the future, it will be possible to analyze regional or inter-hospital differences in the number and characteristics of the patients. Third, the present study did not assess the severity of each case. In the future, it would be useful to identify, measure, and analyze items that can adequately assess the severity of SA, so that appropriate medical resources can be allocated to those who need them. Additionally, an uneven distribution of missing data was observed across the survey items, which could impact the analysis. To address these limitations, we are upgrading the data collection system to reduce the burden on registrars and developing incentives to encourage greater institutional participation. Expanding the registry to include all ECCCs in Japan remains a priority, as this would enable comprehensive data collection on SA presentations nationwide.
Despite these limitations, the JA-RSA offers a valuable dataset that provides critical insights into SA cases. This data will contribute to suicide prevention strategies and guide the allocation of emergency medical resources more effectively.
CONCLUSION
The initial findings from the JA-RSA have outlined key characteristics of SA cases in Japan. Expanding hospital participation and accumulating more case data are essential to enhance the registry's utility. Such efforts will provide invaluable information to support patients with SA and to prevent future reattempts.
ACKNOWLEDGMENTS
The JSEM and JSCP extend their deepest gratitude to all members and institutions participating in JA-RSA for their contributions. A complete list of participating institutions is available in the JA-RSA Annual Report 202412 and will be regularly updated on the project website.9
This registry was made possible through research funding provided by the JSCP, as designated by the Minister of Health, Labor, and Welfare of Japan. We also wish to express our heartfelt thanks to Mr. Chiaki Kawanishi, Mr. Kotaro Otsuka, Mr. Yasuhiro Kishi, and Mr. Kosuke Hino for their dedicated support.
CONFLICT OF INTEREST STATEMENT
The authors declare no conflicts of interest.
ETHICS STATEMENT
The protocol for this research project has been approved by a suitably constituted Ethics Committee of the institution, and it conforms to the provisions of the Declaration of Helsinki. Committee of the Japan Suicide Countermeasures Promotion Center, approval no. JSCP20221111-1.
Open Research
DATA AVAILABILITY STATEMENT
The data that support the findings of this study are available on request to any researcher at institutions participating in the JA-RSA. The data are not publicly available due to privacy and ethical restrictions.